Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2
Discover Oncology · 10.04.2024 · 15 (1)
DOI: 10.1007/s12672-024-00963-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 10.04.2024. Verfasst von Guofu Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Project of Natural Science Foundation of Heilongjiang Province of China, National Natural Science Foundation of China, Foundation for High-Level Returned Overseas Talents of Ministry of Human Resources and Social Security of China..
Abstract (Originalsprache)
Objective
Glioma, a malignant primary brain tumor, is notorious for its high incidence rate. However, the clinical application of temozolomide (TMZ) as a treatment option for glioma is often limited due to resistance, which has been linked to hypoxic glioma cell-released exosomes. In light of this, the present study aimed to investigate the role of exosomal pyruvate kinase M2 (PKM2) in glioma cells that exhibit resistance to TMZ.
Methods
Sensitive and TMZ-resistant glioma cells were subjected to either a normoxic or hypoxic environment, and the growth patterns and enzymatic activity of glycolysis enzymes were subsequently measured. From these cells, exosomal PKM2 was isolated and the subsequent effect on TMZ resistance was examined and characterized, with a particular focus on understanding the relevant mechanisms. Furthermore, the intercellular communication between hypoxic resistant cells and tumor-associated macrophages (TAMs) via exosomal PKM2 was also assessed.
Results
The adverse impact of hypoxic microenvironments on TMZ resistance in glioma cells was identified and characterized. Among the three glycolysis enzymes that were examined, PKM2 was found to be a critical mediator in hypoxia-triggered TMZ resistance. Upregulation of PKM2 was found to exacerbate the hypoxia-mediated TMZ resistance. Exosomal PKM2 were identified and isolated from hypoxic TMZ-resistant glioma cells, and were found to be responsible for transmitting TMZ resistance to sensitive glioma cells. The exosomal PKM2 also contributed towards mitigating TMZ-induced apoptosis in sensitive glioma cells, while also causing intracellular ROS accumulation. Additionally, hypoxic resistant cells also released exosomal PKM2, which facilitated TMZ resistance in tumor-associated macrophages.
Conclusion
In the hypoxic microenvironment, glioma cells become resistant to TMZ due to the delivery of PKM2 by exosomes. Targeted modulation of exosomal PKM2 may be a promising strategy for overcoming TMZ resistance in glioma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
- Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
- Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. changbinshi@hotmail.com.
Förderung
- Key Project of Natural Science Foundation of Heilongjiang Province of China
- National Natural Science Foundation of China
- Foundation for High-Level Returned Overseas Talents of Ministry of Human Resources and Social Security of China.
Zitieren
APA
Li, G., Xiong, Z., Li, Y., Yan, C., Cheng, Y., Wang, Y., Li, J., Dai, Z., Zhang, D., Du, W., Men, C., & Shi, C. (2024). Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-00963-9
Vancouver
Li G, Xiong Z, Li Y, Yan C, Cheng Y, Wang Y, et al. Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-00963-9
BibTeX
@article{Li2024,
author = {Li, Guofu and Xiong, Ziyu and Li, Ying and Yan, Cong and Cheng, Yingying and Wang, Yuwen and Li, Jingwei and Dai, Zifeng and Zhang, Dongdong and Du, Wenzhong and Men, Chunyang and Shi, Changbin},
title = {Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2},
journal = {Discover Oncology},
year = {2024},
volume = {15},
number = {1},
doi = {10.1007/s12672-024-00963-9}
}
EUVIMED